World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
139
Citations
68195
World Ranking
284
National Ranking
192

Medicine

D-Index
139
Citations
70246
World Ranking
1763
National Ranking
1007

Research.com Recognitions

  • 1992 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Gerald J. Gleich is affiliated with the University of Utah in the United States. Their research primarily focuses on medical topics, especially within the field of rheumatology and surgery, as well as physiology, pulmonary and respiratory medicine, and immunology. The research scope includes clinical and translational studies related to eosinophilic disorders and related syndromes.

The main topics covered in their work include:

  • Eosinophilic Esophagitis
  • Eosinophilic Disorders and Syndromes
  • Asthma and respiratory diseases
  • Urticaria and Related Conditions
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • IL-33, ST2, and ILC Pathways
  • Allergic Rhinitis and Sensitization

Some of the venues where Gerald J. Gleich has published frequently are:

  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Allergy
  • Journal of Leukocyte Biology
  • Alimentary Pharmacology & Therapeutics

Their recent published papers include:

  • "Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial" (2020) in the Journal of Allergy and Clinical Immunology
  • "Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes" (2022) in Allergy
  • "Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study" (2021) in The Journal of Allergy and Clinical Immunology In Practice
  • "Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5" (2022) in The Journal of Allergy and Clinical Immunology In Practice
  • "Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disorders" (2022) in Allergy

Frequent co-authors collaborating with Gerald J. Gleich include:

  • Florence Roufosse
  • Marc E. Rothenberg
  • Amy D. Klion
  • Praveen Akuthota
  • Jean-Emmanuel Kahn

Their work has concentrated on clinical immunology and allergic diseases, with a significant emphasis on eosinophilic conditions and therapeutic interventions involving agents like mepolizumab. The selected papers reflect involvement in clinical trials and development of refined diagnostic criteria in eosinophil-related disorders.

Gerald J. Gleich has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 1992. They are also a member of the Association of American Physicians.

Best Publications

  • A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica

    Claudia F. Lucchinetti;Raul N. Mandler;Dorian McGavern;Wolfgang Bruck

  • Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.

    A. J. Wardlaw;Sandra Dunnette;G. J. Gleich;J. V. Collins

  • Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.

    Emilio Pizzichini;Marcia M. M. Pizzichini;Ann Efthimiadis;Susan Evans

  • The Eosinophilic Leukocyte: Structure and Function

    Gerald J. Gleich;Cheryl R. Adolphson

  • Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense

    Shida Yousefi;Jeffrey A. Gold;Nicola Andina;James J. Lee

  • Establishment of an immature mast cell line from a patient with mast cell leukemia.

    J. H. Butterfield;D. Weiler;G. Dewald;Gerald J. Gleich

  • Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

    Michael E. Wechsler;Praveen Akuthota;David Jayne;Paneez Khoury

  • Mechanisms of eosinophil-associated inflammation.

    Gerald J. Gleich

  • The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A

    James B. Lawrence;Claus Oxvig;Michael T. Overgaard;Lars Sottrup-Jensen

  • The eosinophil and the pathophysiology of asthma

    E. Frigas;G.J. Gleich

  • The eosinophil and bronchial asthma: Current understanding

    Gerald J. Gleich

  • Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

    Peter Valent;Amy D. Klion;Hans-Peter Horny;Florence Roufosse

  • Sudden-Onset Fatal Asthma: A Distinct Entity with Few Eosinophils and Relatively More Neutrophils in the Airway Submucosa?

    Sanjiv Sur;Thomas B. Crotty;Gail M. Kephart;Bruce A. Hyma

  • Cytotoxic Properties of the Eosinophil Major Basic Protein

    Gerald J. Gleich;Evangelo Frigas;David A. Loegering;Donald L. Wassom

  • The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.

    G O Solley;G J Gleich;R E Jordon;A L Schroeter

  • Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

    Princess U. Ogbogu;Bruce S. Bochner;Joseph H. Butterfield;Gerald J. Gleich

  • Bronchoalveolar Cell Profiles of Asthmatic and Nonasthmatic Subjects

    John G. Kirby;Frederick E. Hargreave;Gerald J. Gleich;Paul M. O'Byrne

  • Treatment of patients with the hypereosinophilic syndrome with mepolizumab

    Marc E. Rothenberg;Amy D. Klion;Florence E. Roufosse;Jean Emmanuel Kahn

  • Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema

    Marco Cicardi;Aleena Banerji;Francisco Bracho;Alejandro Malbrán

  • Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium.

    E. Frigas;D. A. Loegering;Gerald J. Gleich

Frequent Co-Authors

Kristin M. Leiferman
Kristin M. Leiferman University of Utah
Hirohito Kita
Hirohito Kita Mayo Clinic
Steven J. Ackerman
Steven J. Ackerman University of Illinois at Chicago
Peter F. Weller
Peter F. Weller Beth Israel Deaconess Medical Center
Amy D. Klion
Amy D. Klion National Institutes of Health
Sanjiv Sur
Sanjiv Sur The University of Texas Medical Branch at Galveston
Stephen Naylor
Stephen Naylor Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens up a range of related online degrees and career options. If you’re interested in health sciences, you may want to consider specialized programs such as the accelerated kinesiology degree online, which can fast-track your pathway toward roles in physical therapy, fitness, or sports medicine.

Nursing is another growing field for science graduates. For those already holding a master’s degree, the shortest online nurse practitioner program and shortest pmhnp certificate program offer efficient options to advance toward high-demand positions in family practice or psychiatric mental health.

Nutrition science also appeals to many biology and biochemistry students. If affordability is a priority, check out the cheapest online nutrition degree programs to kickstart your career in dietetics, wellness, or food technology.

These online programs provide flexible, convenient pathways—whether you’re seeking entry-level jobs or looking to boost your qualifications in health-related fields.

Best Scientists Citing Gerald J. Gleich

Trending Scientists